Entry |
|
Name |
Omipalisib (USAN/INN) |
Formula |
C25H17F2N5O3S
|
Exact mass |
505.1020
|
Mol weight |
505.50
|
Structure |
|
Class |
Antineoplastic
DG03139 PI3K inhibitor
|
Efficacy |
Antineoplastic, Phosphatidylinositol 3-kinase inhibitor |
Target |
|
Pathway |
|
Brite |
Drug groups [BR:br08330]
Antineoplastic
DG03139 PI3K inhibitor
D10718 Omipalisib
Target-based classification of drugs [BR:br08310]
Protein kinases
Serine/threonine kinases
Other
MTOR
D10718 Omipalisib (USAN/INN)
Enzymes
Transferases (EC2)
Phosphotransferase
PIK3C
D10718 Omipalisib (USAN/INN)
|
Other DBs |
|
KCF data |
ATOM 36
1 C8x C 18.6026 -13.3570
2 C8x C 18.6026 -14.7555
3 C8y C 19.8137 -15.4548
4 C8x C 21.0250 -14.7555
5 C8y C 21.0250 -13.3570
6 C8y C 19.8137 -12.6577
7 C8y C 22.2361 -12.6577
8 C8x C 22.2361 -11.2592
9 C8x C 21.0250 -10.5599
10 N5x N 19.8137 -11.2592
11 C8y C 23.4472 -13.3570
12 C8y C 19.8137 -16.8533
13 C8x C 23.4472 -14.7554
14 N5x N 24.6585 -15.4547
15 N5x N 25.8696 -14.7554
16 C8x C 25.8696 -13.3570
17 C8x C 24.6585 -12.6577
18 C8x C 18.5859 -17.5624
19 C8y C 18.5860 -18.9609
20 C8y C 19.7973 -19.6601
21 N5x N 21.0252 -18.9510
22 C8x C 21.0250 -17.5525
23 O2a O 19.7973 -21.0586
24 C1a C 18.5861 -21.7579
25 S4a S 16.1637 -18.9612
26 N1b N 17.3750 -19.6604
27 C8y C 14.9525 -18.2620
28 O3c O 16.8630 -17.7501
29 O3c O 15.4645 -20.1724
30 C8x C 14.9524 -16.8534
31 C8x C 13.7413 -16.1543
32 C8y C 12.5301 -16.8535
33 C8x C 12.5302 -18.2622
34 C8y C 13.7415 -18.9613
35 X F 11.3190 -16.1543
36 X F 13.7415 -20.3599
BOND 40
1 1 2 1
2 2 3 2
3 3 4 1
4 4 5 2
5 5 6 1
6 1 6 2
7 5 7 1
8 7 8 2
9 8 9 1
10 9 10 2
11 6 10 1
12 7 11 1
13 3 12 1
14 11 13 1
15 13 14 2
16 14 15 1
17 15 16 2
18 16 17 1
19 11 17 2
20 12 18 1
21 18 19 2
22 19 20 1
23 20 21 2
24 21 22 1
25 12 22 2
26 20 23 1
27 23 24 1
28 25 26 1
29 19 26 1
30 25 27 1
31 25 28 2
32 25 29 2
33 27 30 2
34 30 31 1
35 31 32 2
36 32 33 1
37 33 34 2
38 27 34 1
39 32 35 1
40 34 36 1
|